Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

First look inside Sygnature Discovery’s new £30 million HQ – the “Discovery Building”

Dr Jonathan Williams, COO, has given the “Nottingham Post” a tour of the “Discovery Building”, Sygnature’s new “landmark” facility located in BioCity Nottingham.  The company will begin the move into the new, state-of-the-art building later this month.

Dr Williams told the “Nottingham Post”:

“After Oxford, Cambridge and London, Nottingham is probably the most vibrant area for bioscience research in the country.  Internationally, it’s difficult to know where it stands but Sygnature and other companies at BioCity have contracts worldwide.”

“For the past 12 years-plus, Sygnature Discovery has been doing really well but has got on with its business quite quietly.  This will really raise the profile of the company and of Nottingham in terms of what’s going on here.”

To read the “Nottingham Post” article in full, go to: http://www.nottinghampost.com/first-look-inside-biocity-s-new-30m-biosciences-hub-that-illuminates-at-night/story-30261085-detail/story.html

Latest News

View All

RenaSci’s Sharon Cheetham awarded BPS Fellowship

Sygnature Discovery invests in high-throughput screening capability

Sygnature Discovery moves US base to Kendall…

Sygnature Discovery raises over £2,776 for Cancer…

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.